We have made improvements to Chinese text recognition in the image-based search feature.
Australian Trade Mark Search is the Australian Government’s trade mark search system.
Convention priority claimed: 22 July 2015, United States of America, No. 86/701332 in respect of CHEMICAL AND BIOCHEMICAL PRODUCTS FOR USE IN GENE DELIVERY TECHNOLOGY, NAMELY, NUCLEIC ACIDS, INCLUDING CODING AND NON-CODING DEOXYRIBONUCLEIC ACIDS, RIBONUCLEIC ACIDS, PLASMIDS, VECTORS, PROMOTORS, ENHANCERS AND OTHER REGULATORY SEQUENCES, ALL FOR IN-VIVO USE IN GENE THERAPY; CHEMICAL PRODUCTS, REAGENTS, AND BIOMOLECULES USED FOR SCIENTIFIC AND MEDICAL PURPOSES in class 1; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GENETIC DISEASES AND DISORDERS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF LIVER, HEPATOLOGICAL, CARDIOVASCULAR, CENTRAL NERVOUS SYSTEM, ENDOCRINE, GASTROINTESTINAL, IMMUNOLOGICAL, DERMATOLOGICAL, INFECTIOUS, INFLAMMATORY, MENOPAUSAL, METABOLIC, AUTOIMMUNE, MUSCULOSKELETAL, NEUROLOGICAL, OPHTHALMOLOGIC, PSYCHIATRIC, RESPIRATORY, UROGENITAL, UROLOGICAL, HEMATOLOGIC, AND FUNGAL AND VIRAL DISEASES AND DISORDERS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, PAIN, DIABETES, DAMAGED SKIN, DAMAGED TISSUE AND ADDICTION; GENE THERAPY AND PROPHYLAXIS PRODUCTS, NAMELY, GENE TRANSFER, REGULATION, MODULATION AND DELIVERY PHARMACEUTICALS FOR THE TREATMENT OF GENETIC DISEASES AND DISORDERS; GENE THERAPY AND PHROPHYLAXIS PRODUCTS FOR THE TREATMENT OF LIVER, HEPATOLOGICAL, CARDIOVASCULAR, CENTRAL NERVOUS SYSTEM, ENDOCRINE, GASTROINTESTINAL, IMMUNOLOGICAL, DERMATOLOGICAL, INFECTIOUS, INFLAMMATORY, MENOPAUSAL, METABOLIC, AUTOIMMUNE, MUSCULOSKELETAL, NEUROLOGICAL, OPHTHALMOLOGIC, PSYCHIATRIC, RESPIRATORY, UROGENITAL, UROLOGICAL, HEMATOLOGIC, FUNGAL AND VIRAL DISEASES AND DISORDERS in class 5; BIOMEDICAL AND SCIENTIFIC RESEARCH IN THE FIELDS OF GENOME EDITING, GENE EDITING, GENOME ENGINEERING, GENE MODULATION, GENETIC DISEASES, GENE THERAPY, AND CELL THERAPY; DEVELOPMENT OF PRODUCTS BEING GENETIC THERAPIES AND EFFECTORS TO REGULATE, MODULATE, AND CHARACTERIZE DISEASE STATES; PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF GENE THERAPY; CONDUCTING CLINICAL TRIALS FOR OTHERS IN THE FIELD OF GENE THERAPY DESIGN AND DELIVERY; BIOMEDICAL RESEARCH IN THE FIELD OF GENE THERAPY DESIGN AND DELIVERY; AND COMPANION DIAGNOSTICS AND ASSAYS SERVICES IN THE FIELD OF GENE THERAPY DESIGN AND DELIVERY in class 42; PROVIDING MEDICAL SERVICES, NAMELY, GENE THERAPY DESIGN AND DELIVERY SERVICES IN THE FIELD OF GENETIC DISEASES AND DISORDERS, PROVIDING MEDICAL SERVICES, NAMELY, GENE THERAPY DESIGN AND DELIVERY SERVICES IN THE FIELD OF LIVER, HEPATOLOGICAL, CARDIOVASCULAR, CENTRAL NERVOUS SYSTEM, ENDOCRINE, GASTROINTESTINAL, IMMUNOLOGICAL, DERMATOLOGICAL, INFECTIOUS, INFLAMMATORY, MENOPAUSAL, METABOLIC, AUTOIMMUNE, MUSCULOSKELETAL, NEUROLOGICAL, OPHTHALMOLOGIC, PSYCHIATRIC, RESPIRATORY, UROGENITAL, UROLOGICAL, HEMATOLOGIC, FUNGAL AND VIRAL DISEASES AND DISORDERS; AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, PAIN, DIABETES, DAMAGED SKIN, DAMAGED TISSUE AND ADDICTION in class 44.*
Date:
Number:
Country:
Description:
No oppositions information available.
| Date | Description | |
|---|---|---|
| 12 Nov 2025 | Renewal Reminder correspondence sent | |
| 16 Jun 2016 | IP Right Registration Published | |
| 08 Jun 2016 | Application Status | |
| 08 Jun 2016 | Register Trade Mark | |
| 30 May 2016 | Registration fee (4 classes) | |
| 31 Mar 2016 | IP Right Acceptance Published | |
| 21 Mar 2016 | Application Accepted correspondence sent | |
| 21 Mar 2016 | Clear Examination report approved | |
| 21 Mar 2016 | User Created Notice correspondence sent | |
| 21 Jan 2016 | IP Right Filed Published | |
| 18 Jan 2016 | Application Status | |
| 14 Jan 2016 | Application Status | |
| 14 Jan 2016 | Application Status | |
| 13 Jan 2016 | Status change to Filed | |
| 12 Jan 2016 | Filing an Electronic Application for a TM 4 Class |
| QUALITY | SCIENCE |
| LIFE | OF |